Azetidin compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

Details for Australian Patent Application No. 2008231789 (hide)

Owner Abbott GmbH & Co. KG

Inventors Unger, Liliane; Turner, Sean Colm; Braje, Wilfried; Wicke, Karsten; Mezler, Mario; Mayrer, Matthias; Schultz, Thomas; Lange, Udo; Drescher, Karla; Haupt, Andreas

Agent Spruson & Ferguson

Pub. Number AU-A-2008231789

PCT Pub. Number WO2008/116833

Priority 07104805.2 23.03.07 EP

Filing date 20 March 2008

Wipo publication date 2 October 2008

International Classifications

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/404 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

15 October 2009 PCT application entered the National Phase

  PCT publication WO2008/116833 Priority application(s): WO2008/116833

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008231797-An ergonomic monitor support device

2008231787-Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor